Healthcare TechnologyNVIDIA's BioNeMo Platform Powers $1.3 Trillion Pharma Industry's AI Pivot Across Three ContinentsSalvado•Apr 18, 2026
HealthcareNVIDIA Captures Global Drug Discovery AI Market Through Eli Lilly, Thermo Fisher DealsSalvado•Apr 14, 2026
HealthcareNVIDIA's BioNeMo Platform Deployed by Eli Lilly, Thermo Fisher, Six Biotech Firms for AI Drug DiscoverySalvado•Apr 11, 2026
HealthNVIDIA's BioNeMo Platform Gains Pharmaceutical Industry Adoption from US to EuropeSalvado•Apr 10, 2026
BiotechNVIDIA BioNeMo Platform Gains Thermo Fisher and Eli Lilly Adoption as Biological AI Market ExpandsSalvado•Mar 22, 2026
BiotechCardiff Oncology's $60M Cash Reserve Gives Five Quarters Before Funding CrisisViaNews Editorial Team•Mar 7, 2026
biotechnologyCardiff Oncology's $500M+ valuation at risk as cancer trial targeting 40-50% of colorectal cases nears Q1 2026 data releaseViaNews Editorial Team•Mar 7, 2026
pharmaceuticalsAustralian biotech Vectus faces delisting as XORTX asset sale threatens capital runwayViaNews Editorial Team•Feb 23, 2026
AnalysisFour Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near MarketViaNews Editorial Team•Feb 15, 2026
